United Kingdom · Report · Written statement
UIN HCWS1391
NHSE policy on masculinising and feminising hormones
Introduced
10 March 2026
Last action
10 March 2026 · Written statement
Status
Commons
Sponsors
—
Subjects
Discovery layer
Source updated
10 March 2026
Summary
Today I am updating the House about NHS England’s decision to consult on a new clinical commissioning policy on the Prescribing of Masculinising or Feminising (MAF) Hormones for children and adolescents with gender incongruence or dysphoria.The safety and...
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 March 2026
Written statement
Today I am updating the House about NHS England’s decision to consult on a new clinical commissioning policy on the Prescribing of Masculinising or Feminising (MAF) Hormones for children and adolescents with gender incongruence or dysphoria.The safety and...
Source: Commons
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-statements/detail/2026-03-10/HCWS1391
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenstatements/statements/1889161
- uk · ws-1889161 · source updated 10 March 2026